A study unravels new stem cell transplant factors that might lead to HIV eradication in the body

by IrsiCaixa

The article shows for the first time that stem cell source, time to achieve full replacement of recipient cells with donor cells and graft-versus-host reactivity might contribute to HIV eradication. T...

Read more

Membrane receptors do not act alone

by Centro Nacional de Biotecnología (CNB)

A study shows that the CXCR4 chemokine receptors form aggregates in the cell membrane to be activated and carry out their function. This aggregation process is regulated by the presence of a ligand, b...

Read more

A biomarker for monitoring tuberculosis treatment responses in HIV-Positive patients

by ISGlobal - Instituto de Salud Global de Barcelona

IP10 kinetics during the first week of TB treatment is associated with bacteriological confirmation at diagnosis in HIV-positive patients, according to a new study led by ISGlobal, an institution supp...

Read more

A protein in blood could facilitate HIV diagnosis and treatment follow-up in low-income countries

by ISGlobal - Instituto de Salud Global de Barcelona

A simple blood test to determine levels of the IP-10 protein in blood could represent a key tool in the diagnosis of recently infected HIV individuals that have not yet developed virus-specific antibo...

Read more

Launch of a clinical trial that will evaluate new therapies to prevent tuberculosis in persons with HIV

by ISGlobal - Instituto de Salud Global de Barcelona

People living with HIV have a higher risk of developing tuberculosis (TB). In order to prevent TB in these patients, the WHO recommends a daily dose of isoniazid (6H) treatment during six months. Howe...

Read more

A therapeutic HIV vaccine clinical trial induces viral control in 5 people without taking antiretroviral therapy

by IrsiCaixa

A clinical trial conducted by the IrsiCaixa AIDS Research Institute and the Fight AIDS Foundation has induced HIV control in 5 people who have been in an antiretroviral pause for 5, 13, 17, 20 and 27 ...

Read more

Hospital Clinic-IDIBAPS coordinates a European project to obtain a functional cure for HIV with immunotherapy

by Fundació Clínic per a la Recerca Biomèdica

In order to achieve this functional cure, the HIVACAR project proposes the administration of a combination of immunotherapy that includes therapeutic vaccines (one of them customized for each patient ...

Read more

A biomarker pattern allows differentiating pre and postseroconversion phases in individuals recently infected with HIV

by ISGlobal - Instituto de Salud Global de Barcelona

A study led by Denise Naniche, ISGlobal researcher, in collaboration with researchers from Irsi-Caixa and the Manhiça Health Research Center (CISM), identifies a series of 4 biomarkers whose levels p...

Read more

A new tool to find latent HIV will advance the current treatment strategies

by UPF - Universitat Pompeu Fabra

A group of researchers at the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and w...

Read more

New antiretroviral drugs decrease chances of HIV sexual transmission

by Institut d'Investigació Biomèdica de Bellvitge

A triple regimen based on an integrase inhibitor decreases viral load in semen very quickly, reducing transmission risk

Read more

HIV combination therapies: are two drugs enough?

by Institut d'Investigació Biomèdica de Bellvitge

IDIBELL Researchers write an editorial for the renowned journal The Lancet HIV discussing the potencial advantages of dual antiretroviral therapies

Read more

BSC and IrsiCaixa create bioinformatics method to predict the effectiveness of drugs with HIV mutations

by IrsiCaixa

BSC has created an automatic platform, available for free via the web, on which researchers can enter a patient’s HIV-1 PR protease genomic sequence and predict the effectiveness of prescribing the ...

Read more
Subscribe to Directory
Write an Article

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

CRB Inverbío y Progenika refuerzan Mecw...

by CRB Inverbío SA SGECR

Mecwins tiene como objetivo proporcionar herramientas nanotecnológica...

Photos Stream